Recent updates to this program clarify that up to two awards will be selected annually. While the base funding remains $600,000, you may now be eligible for additional investment funds depending on your project's needs. Also, please note that applications must feature a single Principal Investigator and focus solely on therapeutics rather than standalone diagnostics or devices.
Funder: Alzheimer's Drug Discovery Foundation
Due Dates: June 1, 2026 (Letter of Intent) | August 17, 2026 (Full proposal, invited)
Funding Amounts: Up to $600,000 over 2 years; milestone-driven; up to two awards annually
Summary: Supports academic drug discovery projects advancing novel therapeutics for Alzheimer’s disease and related dementias, with funding and expert development support.
Key Information: Open to academic investigators in the US, Canada, and UK; excludes anti-amyloid approaches.